European Medicines Agency publishes draft advice on the use of colistin products in animals, for consultation

News Open Access

Like 0

European Medicines Agency publishes draft advice on the use of colistin products in animals, for consultation
Eurosurveillance editorial team¹
View Affiliations Hide Affiliations

Affiliations: ¹ European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Correspondence:
Eurosurveillance editorial team
eurosurveillance ecdc.europa.eu
View Citation Hide Citation

Citation style for this article: Eurosurveillance editorial team. European Medicines Agency publishes draft advice on the use of colistin products in animals, for consultation. Euro Surveill. 2016;21(22):pii=30246. https://doi.org/10.2807/1560-7917.ES.2016.21.22.30246

There is no abstract available.

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.22.30246

2016-06-02

2025-07-03

/content/10.2807/1560-7917.ES.2016.21.22.30246

Full text loading...

/deliver/fulltext/eurosurveillance/21/22/eurosurv-21-22-6.html?itemId=/content/10.2807/1560-7917.ES.2016.21.22.30246&mimeType=html&fmt=ahah

References

The European Medicines Agency (EMA). Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health EMA/231573/2016. London: EMA; 26 May 2016. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/05/WC500207233.pdf
Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill. 2016;21(9):30155. https://doi.org/10.2807/1560-7917.ES.2016.21.9.30155

Submit comment

Comment moderation successfully completed